The National Cancer Institute is participating in a Notice of Special Interest (NOSI), which provides supplements to active grantees to support collaborations that bring together expertise in biomedicine, data management, and artificial intelligence/machine learning (AI/ML). Cancer researchers should apply by March 18, 2022.

Refer to the NOSI for full details on submission requirements and for what activities the supplements may be used.

The initiative is aligned with the NIH Strategic Plan for Data Science, which describes actions aimed at modernizing the biomedical research data ecosystem and making data FAIR (Findable, Accessible, Interoperable, and Reusable) with high impact for open science.

It is the NIH vision to establish a modernized and integrated biomedical data ecosystem that adopts the latest data science technologies, including AI and ML, and best practice guidelines arising from community consensus, such as the FAIR principles, and open-source development. This effort is led by the NIH Office of Data Science Strategy.